Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 550

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 550
---
 geographic information is presented only for revenue.

Fiscal 2024 Form 10-K123

A summary of the segment profit or loss, including significant segment expenses is as follows:Years Ended December 31,(in thousands)202420232022Total revenue154,014 200,521 128,304 Less:Cost of revenue116,732 147,741 79,269 Research and development134,922 187,170 193,000 Sales and marketing87,244 79,287 84,465 General and administrative87,773 90,531 76,389 Impairment charges184,500 — — Merger-related expenses— 9,042 — Change in fair value of contingent consideration(850)15,060 2,377 Amortization of acquired intangible assets18,006 6,157 — Loss on extinguishment of debt— 2,033 — Gain on debt restructuring(154,407)— — Other income (expense), net10,371 18,341 (7,052)Income tax provision (benefit)316 (11,424)— Consolidated net loss(309,851)(306,735)(314,248)A summary of our revenue by geographic location is as follows:Years Ended December 31,(in thousands)202420232022Americas (1)$78,711 $105,410 $69,561 Europe, Middle East, and Africa34,594 40,658 22,598 Asia-Pacific40,709 54,453 36,145 Total $154,014 $200,521 $128,304 (1)     Includes United States revenue of $75.3 million, $100.5 million, and $66.8 million for the years ended December 31, 2024, 2023, and 2022, respectively.A summary of our revenue by category is as follows: Years Ended December 31,(in thousands)202420232022Instrument revenue$65,776 $120,451 $48,719 Consumable revenue70,373 63,421 59,980 Product revenue136,149 183,872 108,699 Service and other revenue17,865 16,649 19,605 Total revenue$154,014 $200,521 $128,304